NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS

摘要

Disclosed is a peptide comprising a sequence that is selected from the group of SEQ ID No. 4 or SEQ ID No. 5 or a variant thereof wherein one amino acid is replaced by an amino acid of similar structure and characteristics that induces T cells cross-reacting with said variant peptide, wherein said peptide is not the underlying full-length polypeptide.